BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells
about
BRCAness: finding the Achilles heel in ovarian cancerMolecular tumor profiling: translating genomic insights into clinical advancesA combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatmentTumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapyBiomarkers in triple negative breast cancer: A reviewCurrent approaches in treatment of triple-negative breast cancerFine tuning chemotherapy to match BRCA1 statusBRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma.Efficacy of neoadjuvant Cisplatin in triple-negative breast cancerThe role of epigenetics in resistance to Cisplatin chemotherapy in lung cancerBRCA1 and Oxidative StressHigh-definition DNA methylation profiles from breast and ovarian carcinoma cell lines with differing doxorubicin resistanceResistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoproteinMicrofluidic cell isolation technology for drug testing of single tumor cells and their clusters.The integrin alpha(v)beta(3-5) ligand MFG-E8 is a p63/p73 target gene in triple-negative breast cancers but exhibits suppressive functions in ER(+) and erbB2(+) breast cancers.CEST-MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy responseIs ovarian cancer a targetable disease? A systematic review and meta-analysis and genomic data investigationEGFR associated expression profiles vary with breast tumor subtypeA phase II study of capecitabine plus cisplatin in metastatic triple-negative breast cancer patients pretreated with anthracyclines and taxanesCurrent data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based?Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer.Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancerSphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitroIscador Qu inhibits doxorubicin-induced senescence of MCF7 cellsTriple-negative breast cancer: role of specific chemotherapy agentsThe efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers.Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells.The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cellsThe prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancerEffect of adriamycin on BRCA1 and PARP-1 expression in MCF-7 breast cancer cells.miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition.BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability.BRCA1 mRNA expression as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma treated with cisplatin- or docetaxel-based chemotherapy/chemoradiotherapy.The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.Enhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cellsA Peptide mimicking a region in proliferating cell nuclear antigen specific to key protein interactions is cytotoxic to breast cancer.The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancersDrug therapy for hereditary cancersBRCA1 germline mutation and glioblastoma development: report of cases.BRCA1 is required for postreplication repair after UV-induced DNA damage
P2860
Q24630872-B4385E50-5508-4354-AD48-64F11BE7AC45Q24797250-C209EC13-0BE5-4EBC-B213-5303A7F85AA9Q24803679-606DFA45-FA65-4465-A705-06318F93E0BAQ26768521-436149BE-1B36-45E1-AE67-E2BC88DDC58DQ26775094-103AF345-F417-4DDE-BEA2-45497E8F0968Q26801549-41DD8BB6-1CE5-4795-BF62-A04BE804F917Q27694529-0BD77409-5AD7-466E-8D97-7319E895BB93Q27851697-BBC094C8-B176-46FD-BE59-B2C4A99E7AF8Q28372484-E42DCFAE-58B4-4C35-9244-A26B92011957Q28387891-C6597D3E-06BC-41FC-8950-B6C90E2D91EBQ28388921-150D05A8-228F-43DB-B166-81584A990023Q28474284-C07AD429-DBDA-41AC-9273-11D8C48BC742Q28481246-C19D1B39-B3F9-4E0B-B0E8-2FED315B366AQ30364122-10896250-63A2-4EC5-9E34-6BEABEBB6F64Q30992805-5F3226EB-1215-4333-8A2A-D69D7DD916ABQ31082468-4007535A-F883-4A2D-A36A-12CE27CEAA2BQ31138109-809F9CB3-42B4-4829-95A8-212608386296Q33292502-C3F010FD-850A-49DB-B60D-AEA024ED9EBEQ33426722-DAF806C9-A987-401B-9EF9-E52A09AF6861Q33500786-FB2AA7DE-B712-4F20-A048-1E8567DA7760Q33539418-E4CD0D46-45D9-4DD9-97E0-2A5EAB31C500Q33704050-4826DEC7-D5DB-409D-A644-8A220EF54DD6Q33727889-FDACAAB5-0E2A-46B4-923C-718DD031BDA2Q33812688-9BAFC3FA-3E85-4436-A89E-F822ADB53A11Q33900930-1295CB0D-E186-41C5-AF84-790236768564Q33962070-84046CB5-417A-4C36-BCD8-E5F694DACD8DQ33965570-499C87CF-D834-4C85-8F7A-5C1BFEA5230FQ34048154-3F283DD0-D870-437B-8CF1-EAE365A8481EQ34102670-3C60A387-E6F7-4704-A2FC-51A9B4D34753Q34371454-901CA87C-5FD2-46AF-93A5-C08ACD11214BQ34380980-D4D524D2-D6BB-4D11-92F4-D3255B4397A6Q34539782-C53E0549-2701-4540-800F-4CA6257E02D8Q34550974-0AE943B2-CD9A-40B6-9437-EA1FCA452AAAQ34581026-EEB1A3EC-2FCF-4DC5-80DF-4F467DDE7D3BQ34647893-6B884997-A4B3-401E-968B-3FE9B6A201E2Q34946808-9371A1FC-CF1A-4C17-81F5-D733E685AFC5Q35014762-182A8907-E6F2-47F4-9DB4-17866C331D0BQ35208929-753C26B4-7F50-42EF-BBE9-7200B1CA7E65Q35226053-3F7D0DF7-8DDD-44DC-AC58-EA1FD58A9868Q35434721-AB7D12F2-1215-46AD-9037-B5E379020D47
P2860
BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2003
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
BRCA1 expression modulates che ...... 1937 human breast cancer cells
@en
BRCA1 expression modulates che ...... 937 human breast cancer cells.
@nl
type
label
BRCA1 expression modulates che ...... 1937 human breast cancer cells
@en
BRCA1 expression modulates che ...... 937 human breast cancer cells.
@nl
prefLabel
BRCA1 expression modulates che ...... 1937 human breast cancer cells
@en
BRCA1 expression modulates che ...... 937 human breast cancer cells.
@nl
P2093
P2860
P356
P1476
BRCA1 expression modulates che ...... 1937 human breast cancer cells
@en
P2093
A Perricelli
B Quaresima
C R Boland
M L Martelli
P Tagliaferri
V Barbieri
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600859
P407
P577
2003-04-01T00:00:00Z